Gene · 2395
Papers2,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uniparental IsoDisomy: a case study on a new mechanism of Friedreich ataxia. | Eur J Hum Genet | 2025 | 39496895 | PubTator, text mining | PubMed |
| Case Report of Friedreich's Ataxia and ALG1 -Related Biochemical Abnormalities in a Patient With Progressive Spastic Paraplegia. | Am J Med Genet A | 2025 | 39324476 | PubTator, text mining | PubMed |
| Insulin Sensitivity and Insulin Secretion in Adults With Friedreich's Ataxia: The Role of Skeletal Muscle. | J Clin Endocrinol Metab | 2025 | 39109797 | PubTator, text mining | PubMed |
| Safety and efficacy of omaveloxolone v/s placebo for the treatment of Friedreich's ataxia in patients aged more than 16 years: a systematic review. | Orphanet J Rare Dis | 2024 | 39736600 | PubTator, text mining | PubMed |
| Plasma miRNAs Correlate with Structural Brain and Cardiac Damage in Friedreich's Ataxia. | Cerebellum | 2024 | 39688804 | PubTator, text mining | PubMed |
| Two-stage binding of mitochondrial ferredoxin-2 to the core iron-sulfur cluster assembly complex. | Nat Commun | 2024 | 39632806 | PubTator, text mining | PubMed |
| Assessment of the Clinical Interactions of GAA Repeat Expansions in FGF14 and FXN. | Neurol Genet | 2024 | 39574782 | PubTator, text mining | PubMed |
| Differential Gene Expression in Late-Onset Friedreich Ataxia: A Comparative Transcriptomic Analysis Between Symptomatic and Asymptomatic Sisters. | Int J Mol Sci | 2024 | 39519164 | PubTator, text mining | PubMed |
| At-home wearable-based monitoring predicts clinical measures and biological biomarkers of disease severity in Friedreich's Ataxia. | Commun Med (Lond) | 2024 | 39468362 | PubTator, text mining | PubMed |
| Corrigendum to "Protective effect of FXN overexpression on ferroptosis in L-Glu-induced SH-SY5Y cells" [Acta Histochem. 126 (2024) 152135]. | Acta Histochem | 2024 | 39343692 | PubTator, text mining | PubMed |
| Skeletal Muscle Involvement in Friedreich Ataxia. | Int J Mol Sci | 2024 | 39337401 | PubTator, text mining | PubMed |
| Unusual Age-Dependent Behavior of Leukocytes Telomere Length in Friedreich's Ataxia. | Mov Disord | 2024 | 39235665 | PubTator, text mining | PubMed |
| A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients. | Children (Basel) | 2024 | 39201893 | PubTator, text mining | PubMed |
| Interplay of FXN expression and lipolysis in white adipocytes plays a critical role in insulin sensitivity in Friedreich's ataxia mouse model. | Sci Rep | 2024 | 39191875 | PubTator, text mining | PubMed |
| FXN targeting induces cell death in ovarian cancer stem-like cells through PRDX3-Mediated oxidative stress. | iScience | 2024 | 39184439 | PubTator, text mining | PubMed |
| A multiple animal and cellular models approach to study frataxin deficiency in Friedreich Ataxia. | Biochim Biophys Acta Mol Cell Res | 2024 | 39134123 | PubTator, text mining | PubMed |
| New and Emerging Drug and Gene Therapies for Friedreich Ataxia. | CNS Drugs | 2024 | 39115603 | PubTator, text mining | PubMed |
| Glial cell activation precedes neurodegeneration in the cerebellar cortex of the YG8-800 murine model of Friedreich ataxia. | Neurobiol Dis | 2024 | 39111701 | PubTator, text mining | PubMed |
| The importance of synthetic pharmacotherapy for recessive cerebellar ataxias. | Expert Rev Neurother | 2024 | 38980086 | PubTator, text mining | PubMed |
| Generation of genetically modified Friedreich's ataxia induced pluripotent stem cell lines and isogenic control lines carrying an inducible neurogenin-2 expression cassette. | Stem Cell Res | 2024 | 38936158 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2395/papers?page=7